Abstract:Objective:To investigate the cognition of the diagnosis and management of bronchiectasis among respiratory specialists.Methods:Between May and June 2020, a questionnaire survey based on expert consensus and guidelines was conducted among respiratory specialists from 50 hospitals from Sichuan and Yunnan provinces. Total 691 questionnaires were distributed and 641 were received. 601 valid questionnaires were chosen for further analysis with an effective recovery rate of 87.0%. The respondents were required to finish the e-questionnaires independently in terms of cognition of diagnosing, severity assessment, treatments and Chinese medicines of bronchiectasis. The responses were collected online and the cognitive levels were evaluated by calculating the correct rates of corresponding questions.Results:540 (89.9%) of the respondents agreed that high-resolution computed tomography (HRCT) was the gold standard for diagnosing of bronchiectasis, but 318 (52.9%) had an incomplete understanding of common radiographic manifestations of bronchiectasis, and different cognitive degrees of common radiographic manifestations of bronchiectasis existed among respondents with different qualifications or working in different levels of hospitals ( P<0.05). Only 118 (19.6%) of the respondents were familiar with severity assessments of bronchiectasis, but 65 (55.1%) of the 118 respondents said they won′t apply these severity assessments to patient during their clinical works. For the treatment of patients with stable bronchiectasis, airway clearance techniques were most recommended by specialists surveyed [410 (68.2%)], among which, postural drainage was the most known method [559 (93.0%)]. For patients undergoing an acute exacerbation, most respondents recommended antibiotics [600 (99.8%)] as the primary treatment, and examinations such as sputum culture [544 (90.5%)], inflammatory markers [523 (87.0%)] should be performed as well. 504 (83.9%) thought that pseudomonas aeruginosa was the most common conditioned pathogen for bronchiectasis. For patients with frequent exacerbations (≥3 per year), 385 (64.1%) of the respondents supported the therapeutic effect of long-term antibiotics, however, among the 385 respondents supporting long-term antibiotics, only [113 (29.4%)] were willing to recommend long-term antibiotic treatment actively during their clinical practice. Besides, 304 (50.6%) respondents held a positive attitude to the clinical effect of traditional Chinese medicine therapies. Among 304 respondents holds the point of supporting, only 86 (28.3%) were willing to recommend traditional Chinese medicine to patients actively, differences about the attitude and clinical behaviors were found between respondents working in different levels of hospitals ( P<0.05). Conclusions:Respiratory specialists′ cognition on diagnosis and treatments of bronchiectasis remains inadequate, and cognitive levels differ among respondents working in different levels of hospitals. There is a gap between respondents′ cognition and clinical practice. Further education and trainings are necessary for improving respiratory specialists′ knowledge for timely diagnosis and standard treatment of bronchiectasis.

Progress of Diagnosis and Treatment on Adult Non-Cystic Fibrosis Bronchiectasis

Bronchiectasis in China: Present Situations and Challenges

Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines

Research Advances and Clinical Management of Bronchiectasis: Chinese Perspective

The immunoregulatory mechanism of bronchiectasis and the progress of immunomodulatory therapy

Reversible adult bronchiectasis:a case report and a literature review

[Chinese expert consensus on the etiological diagnosis of adult bronchiectasis]

Annual review of bronchiectasis in 2020

Current management of bronchiectasis: review and 3 case studies

Management of bronchiectasis in adults

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

Characterization of pathogenic infections in bronchiectasis and advances in precise diagnosis and anti-infective therapy

Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysis

Exacerbation Prevention and Management of Bronchiectasis

Progress of respiratory infection and colonization in noncystic fibrosis bronchiectasis

Pathophysiology, causes and genetics of paediatric and adult bronchiectasis

Progress in the treatment of bronchiolitis obliterans

Cognition on diagnosis and treatments of bronchiectasis among respiratory specialists

Advantages and Drawbacks of Long-Term Macrolide Use in the Treatment of Non-Cystic Fibrosis Bronchiectasis.

The analysis of clinical characteristics and treatment methods about patients with bronchial asthma complicated with bronchiectasis

Etiology and Clinical Features of Children with Bronchiectasis in China: A 10-Year Multicenter Retrospective Study.